Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

PURPOSE: There is no effective therapy for patients with distant metastasis of medullary thyroid carcinoma (MTC). Activating mutations in the RET proto-oncogene cause hereditary MTC, which provides a strong therapeutic rationale for targeting RET kinase activity. This open-label, phase II study asse...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wells, Samuel A., Gosnell, Jessica E., Gagel, Robert F., Moley, Jeffrey, Pfister, David, Sosa, Julie A., Skinner, Michael, Krebs, Annetta, Vasselli, James, Schlumberger, Martin
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2010
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2834392/
https://ncbi.nlm.nih.gov/pubmed/20065189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.23.6604
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars